Clinical Trial Update: Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD)

View source ↗

Summary

Retrospective real-world database study evaluating outcomes of Abilify in patients with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Depressive Disorder, Major | Status: COMPLETED